ProQR Therapeutics | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ProQR Therapeutics | 424B5: Prospectus
ProQR Therapeutics | 424B5: Prospectus
ProQR Therapeutics | EFFECT: Others
ProQR Therapeutics | 424B5: Prospectus
ProQR Therapeutics | CORRESP: CORRESP
ProQR Therapeutics | UPLOAD: Others
ProQR Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]